Your 'Time Personality' Is Doing a Number on Your Finances
How Much Money Do You Need to Retire?
17 Tips for Saving on Back-to-School Shopping
Market Wrap: S&P 500 Sets a New Record on Job Gains, Earnings
Johnson & Johnson Launches Offer for Crucell
Giant drugmaker Johnson & Johnson has agreed to buy Dutch vaccine maker Crucell. The deal will give J&J a bigger piece of the vaccine market and better access to emerging markets.
Still in hot water over its "phantom recall" of a Motrin product, Johnson & Johnson looks to expand its share of the vaccine market with purchase of Dutch pharma company Crucell.
Novavax (NVAX) shares soared some 10 percent today after the small clinical-stage biotechnology company announced positive preclinical results for...